Citation Impact
Citing Papers
Lymphoma Recurrence 5 Years or Later Following Diffuse Large B-Cell Lymphoma: Clinical Characteristics and Outcome
2010
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
2010 Standout
Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation
2009
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
1999
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
MANUAL THERAPY IN THE TREATMENT OF NECK PAIN
1996
Combination and Sequential Antifungal Therapy for Invasive Aspergillosis: Review of Published In Vitro and In Vivo Interactions and 6281 Clinical Cases from 1966 to 2001
2003
A Critical Appraisal of Review Articles on the Effectiveness of Conservative Treatment for Neck Pain
2001 Standout
Leishmaniasis
2018 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Neutrophils at work
2014 Standout
Advances in stem cell mobilization
2012
Itraconazole to Prevent Fungal Infections in Chronic Granulomatous Disease
2003
The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis
2005
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Oral Anticoagulant Therapy
2012 Standout
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease
2011 Standout
The existence and role of microchimerism after microtransplantion
2014
Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004
2005
Differential toxicity of antimonial compounds and their effects on glutathione homeostasis in a human leukaemia monocyte cell line
2005
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Vascular disorders of the liver # †
2008 Standout
The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration
2005
Apply traditional and molecular protocols for the detection of carrier state of visceral leishmaniasis in black Bengal goat
2014
Strategies for overcoming p-glycoprotein-mediated drug resistance in acute myeloblastic leukaemia
2004
Targeting multidrug resistance in cancer
2006 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Classical and Nonclassical HLA Class I Antigen and NK Cell–Activating Ligand Changes in Malignant Cells: Current Challenges and Future Directions
2005
A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation
2004
Canine Leishmaniasis
2004
Echinocandin antifungal drugs
2003 Standout
Patterning network structure to spatially control cellular remodeling and stem cell fate within 3-dimensional hydrogels
2010
Portal vein thrombosis in adults: pathophysiology, pathogenesis and management
2000
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia
2001
Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers
2002
Manual Examination of the Spine: A Systematic Critical Literature Review of Reproducibility
2006
Interexaminer reliability in physical examination of the cervical spine
1999
HLA-G Molecules: from Maternal–Fetal Tolerance to Tissue Acceptance
2003
Cancer-related inflammation and treatment effectiveness
2014 Standout
Degradation-mediated cellular traction directs stem cell fate in covalently crosslinked three-dimensional hydrogels
2013 Standout
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes
2016 StandoutNobel
Topoisomerase I inhibitors: camptothecins and beyond
2006 Standout
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
2009 Standout
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed
2010 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
High level of soluble HLA-G in amniotic fluid is correlated with congenital transmission of Toxoplasma gondii
2010
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
TK.007: A Novel, Codon-Optimized HSVtk(A168H) Mutant for Suicide Gene Therapy
2010
Concise Review: Clinical Relevance of Drug–Drug and Herb–Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein)
2007
Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells
2007 Standout
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
2003 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Multidrug resistance protein attenuates gemtuzumab ozogamicin–induced cytotoxicity in acute myeloid leukemia cells
2003
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies
2003
Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
1997
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Advances in leishmaniasis
2005 Standout
Human Neuroblastoma Cells Trigger an Immunosuppressive Program in Monocytes by Stimulating Soluble HLA-G Release
2007
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders
2007
Polycythemia vera: myths, mechanisms, and management
2002
Fibroblast Growth Factor 2-Mediated Translational Control of IAPs Blocks Mitochondrial Release of Smac/DIABLO and Apoptosis in Small Cell Lung Cancer Cells
2003
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Designing Cell-Compatible Hydrogels for Biomedical Applications
2012 StandoutScience
Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies
2004
The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin
2004
Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis
2007
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
The Kappa Statistic in Reliability Studies: Use, Interpretation, and Sample Size Requirements
2005 Standout
Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
2000
Drug Resistance in Leishmaniasis
2006 Standout
The Role of Mitochondria in Apoptosis
2009 Standout
Works of Marc Bernard being referenced
Intra and interexaminer reliability of motion palpation in the cervical spine
1985
High multidrug resistance protein activity in acute myeloid leukaemias is associated with poor response to chemotherapy and reduced patient survival
2002
Inhibition of human mesenchymal stem cell-derived adipogenesis by the environmental contaminant benzo(a)pyrene
2009
Inapparent Polycythemia Vera: An Unrecognized Diagnosis
1997
HLA-G and lymphoproliferative disorders
2003
Major histocompatibility complex abnormalities in non‐Hodgkin lymphomas
2002
Prophylactic Use of Itraconazole for the Prevention of Invasive Pulmonary Aspergillosis in High Risk Neutropenic Patients
1998
Soluble HLA-G Molecules Are Increased during Acute Leukemia, Especially in Subtypes Affecting Monocytic and Lymphoid Lineages'
2006
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study
2001
Soluble HLA-G molecules are increased in lymphoproliferative disorders
2003
Potassium antimonyl tartrate induces caspase‐ and reactive oxygen species‐dependent apoptosis in lymphoid tumoral cells
2002
Comparison of Lenograstim vs Filgrastim Administration following Chemotherapy for Peripheral Blood Stem Cell (PBSC) Collection: A Retrospective Study of 126 Patients
1999
Visceral leishmaniasis in a dog: clinical, hematological and pathological observations.
1977
Late Relapse of Localized High-Grade Non-Hodgkin’s Lymphoma: Clinical and Biological Features
2008
Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay.
1995
Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction
2002
Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia
2003